FDA's Robert Califf calls on insurers to help providers participate in critical clinical drug trials

Insurers must do more to help providers participate in clinical trials that can confirm the effectiveness of drugs granted accelerated approval, Food and Drug Administration Commissioner Robert Califf, M.D., told a room full of payer executives Thursday.